KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Accumulated Expenses (2016 - 2025)

Teladoc Health's Accumulated Expenses history spans 12 years, with the latest figure at $96.3 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 26.27% year-over-year to $96.3 million; the TTM value through Dec 2025 reached $96.3 million, up 26.27%, while the annual FY2025 figure was $96.3 million, 26.27% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $96.3 million at Teladoc Health, up from $76.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $102.7 million in Q4 2023 and bottomed at $5.8 million in Q3 2022.
  • The 5-year median for Accumulated Expenses is $66.7 million (2023), against an average of $65.7 million.
  • The largest annual shift saw Accumulated Expenses tumbled 92.34% in 2022 before it surged 1361.22% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $91.9 million in 2021, then dropped by 11.3% to $81.6 million in 2022, then rose by 25.91% to $102.7 million in 2023, then decreased by 25.76% to $76.2 million in 2024, then grew by 26.27% to $96.3 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Accumulated Expenses are $96.3 million (Q4 2025), $76.8 million (Q3 2025), and $70.3 million (Q2 2025).